Muyong, Esnia C.

HRN: 24-44-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2024
CEFUROXIME 1.5GM (VIAL)
01/16/2024
01/17/2024
IV
1.5 Grams
Now Only
For STAT CS With BTL
Waiting Final Action 
01/17/2024
CEFUROXIME 1.5GM (VIAL)
01/17/2024
01/24/2024
IVT
1.5 Gm
Q 8h
S/P CS W/ BTL
Waiting Final Action 
01/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/17/2024
01/24/2024
IVT
500 Mg
Q 8h
S/P CS W/ BTL
Waiting Final Action 
01/17/2024
CEFUROXIME 500MG (TAB)
01/17/2024
01/20/2024
PO
500 Mg
BID
S/P CS W/ BTL
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: